RESUMEN
The copper complex of a polydentate non-symmetrical Schiff base ligand [LCu]2, prepared by template synthesis, has been reacted with the series of lanthanide ions. This complex used as a ligand possesses two functions (phenol and oxime) able to coordinate the Ln ions and, according to the Ln ion, three types of complexes are obtained. From La to Eu, trinuclear [(LCu)2Ln(NO3)3] complexes with a double phenoxo-oximato bridge were isolated. From Gd to Ho, the complexes [(LCu)2Ln(NO3)3(H2O)] are still trinuclear, with a supplementary water molecule linked to the Ln ion but the Cu(II) and Ln(III) ions are only bridged by the oximato (N-O) pair, the phenoxo oxygen atom being hydrogen-bridged to the Ln-coordinated water molecule. Then, with heavier Ln ions, dinuclear [(LCu)Ln(NO3)3(H2O)2] complexes are characterized. The magnetic study demonstrates that the oximato bridge is responsible for the antiferromagnetic character of the Cu-Gd interaction, with JCuGd = -0.63 cm(-1) in [(LCu)2Gd(NO3)3(H2O)], in contrast to the ferromagnetic Cu-Gd interaction induced by the single oxygen atom phenoxo bridge.
RESUMEN
New series of phosphorus-containing dendrimers, having one quaternary ammonium salt as core and carboxylic acid terminal groups have been synthesized from generation 0 (3 carboxylic acid terminal groups) to generation 2 (12 carboxylic acid terminal groups). These dendrimers react with the neutral form of carteolol (an ocular anti-hypertensive drug used to treat glaucoma) to afford ion pair (saline) species. The solubility in water of these charged dendrimers depends on the generation considered: generation 0 (3 carteolol) is well soluble, whereas generation 1 (6 carteolol) and generation 2 (12 carteolol) are poorly soluble. These dendrimers have been tested in vivo, as vehicle for ocular drug delivery of carteolol to rabbits.